Skip to content
BOLTBolt Biotherapeutics, Inc.

BOLT holders

Who holds Bolt Biotherapeutics, Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.

Moves this quarter

Among the largest holders, against their report a quarter earlier.
Managers
23
Shares held
576.4K
Value held
$2.1M
Opened
1
Closed
1

Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.

ManagerSharesChangeValueOf portfolioFiled
Sofinnova Investments, Inc.137.7K±0%$506.8K0.1%Nov 16, 2026
Renaissance Technologies LLC92.9K−5.8%$342K0.1%Nov 12, 2026
Vivo Capital, LLC72.4K±0%$266.5K0.1%Nov 13, 2026
T3 Companies, LLC38K±0%$139.8K0.1%Oct 22, 2026
Board of Trustees of The Leland Stanford Junior University36K±0%$132.4K0.1%Nov 16, 2026
Lynx1 Capital Management LP30.8K±0%$113.3K0.1%Nov 16, 2026
Pfizer Inc31.3K±0%$112.1K0.1%Nov 12, 2026
Nano CAP New Millennium Growth Fund L P27.5K±0%$101.2K0.1%Nov 13, 2026
Citadel Advisors LLC18.3K−67.8%$67.3K0%Nov 16, 2026
Susquehanna International Group, LLP16.8KNew$62K0%Nov 16, 2026
Shay Capital LLC16.5K+7.0%$60.8K0.1%Nov 16, 2026
Geode Capital Management, LLC15.8K−17.4%$58.1K0%Nov 6, 2026
Vanguard Fiduciary Trust Co15.5K+401.9%$57.2K0%Nov 13, 2026
BlackRock, Inc.9.7K±0%$35.7K0%Nov 13, 2026
Vanguard Capital Management LLC7.1K±0%$26K0%Nov 13, 2026
Nan Fung Group Holdings Ltd5K±0%$18.4K0.1%Nov 13, 2026
Morgan Stanley4.2K+32.5%$15.3K0%Nov 13, 2026
Tower Research Capital LLC (TRC)500−70.8%$1.8K0%Nov 16, 2026
JPMorgan Chase & Co290+590.5%$1.1K0%Nov 12, 2026
SBI Securities Co., Ltd.10−92.3%$370%Oct 22, 2026
Barclays PLC6±0%$220%Nov 6, 2026
UBS Group AG2−99.2%$70%Nov 10, 2026
Citigroup Inc1−97.6%$40%Nov 4, 2026